Zmiana wielkości czcionki:

A A A

prof. Maria Barcikowska

Prywatny Gabinet Neurologiczny

slide_jesien
slide_zima
slide_wiosna
slide_lato

Publikacje

PRACE ORYGINALNE: OSTATNIE 10 LAT

Gabryelewicz T, Pawlowska-Detko A, Misko J, Cwikla JB, Pfeffer A, Barczak A, Wasiak B, Luczywek E, Krolicki L, Walecki J, Barcikowska M. Prediction of deterioration of mild cognitive impairment with CT and SPECT ,Med Sci Monit , 13 Suppl 1,31-37, 2007Maruszak A, Safranow K, Gacia M, Gabryelewicz T, Slowik A, Styczynska M, Peplonska B, Golan MP, Zekanowski C, Barcikowska M. ;Sigma receptor type 1 gene variation in a group of Polish patients with Alzheimer’s disease and mild cognitive impairment, Dement Geriatr Cogn Disord, 23 (6),432-438, 2007

Łuczywek E, Gabryelewicz T, Barczak A, Religa D, Pfeffer A, Styczynska M, Peplonska B, Chodakowska-Zebrowska M, Barcikowska M. ; Neurocognition of centenarians: neuropsychological study of elite centenarians, Int J Geriatr Psychiatry, 21,1-5, 2007

Golan MP, Styczyńska M, Jóźwiak K, Walecki J, Maruszak A, Pniewski J, Lugiewicz R, Filipek S, Zekanowski C, Barcikowska M. Early-onset Alzheimer’s disease with a de novo mutation in the presenilin 1 gene. Exp Neurol. Dec;208(2):264-8 ,2007

Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, Kapaki E, Tsolaki M, Daniilidou M, Molyva D, Paraskevas GP, Thal DR, Barcikowska M, Kuznicki J, Lannfelt L, Van Broeckhoven C, Nitsch RM, Hock C, Papassotiropoulos A.; Association study of cholesterol-related genes in Alzheimer’s disease, Neurogenetics,8(3),179-188 , 2007

Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, Chodakowska-Zebrowska M, Wasiak B, Peplonska B, Barcikowska M.;The rate of conversion of mild cognitive impairment to dementia: predictive role of depression, Int J Geriatr Psychiatry, 22 (6) , 563-567, 2007

Golanska E, Sieruta M, Gresner SM, Hulas-Bigoszewska K, Corder EH, Styczynska M, Peplonska B, Barcikowska M, Liberski PP. Analysis of APBB2 gene polymorphisms in sporadic Alzheimer’s disease. Neurosci Lett. Dec 12;447(2-3):164-6, 2008

Erickson RP, Larson-Thomé K, Weberg L, Szybinska A, Mossakowska M, Styczynska M, Barcikowska M, Kuznicki J. Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population.Neurosci Lett. Dec 12;447(2-3):153-7, 2008

Gaweda-Walerych K, Maruszak A, Safranow K, Bialecka M, Klodowska-Duda G, Czyzewski K, Slawek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Canter JA, Barcikowska M, Zekanowski C. Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson’s disease risk in a Polish PD cohort.J Neural Transm. Nov;115(11):1521-6, 2008

Ross OA, Soto AI, Vilarino-Güell C, Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Genetic variation of Omi/HtrA2 and Parkinson’s disease. Parkinsonism Relat DisordNov;14(7):539-43, 2008.

Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilarino-Güell C, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine beta-hydroxylase -1021C>T association and Parkinson’s disease.Parkinsonism Relat Disord. Nov;14(7):544-7, 2008.

Golan MP, Melquist S, Safranow K, Styczyńska M, Słowik A, Kobryś M, Zekanowski C, Barcikowska M. Analysis of UBQLN1 variants in a Polish Alzheimer’s disease patient: control series.Dement Geriatr Cogn Disord. 25(4):366-71,2008;.

Baranowska-Bik A, Bik W, Wolinska-Witort E, Martynska L, Chmielowska M, Barcikowska M, Baranowska B. Plasma beta amyloid and cytokine profile in women with Alzheimer’s disease.Neuro Endocrinol Lett. Feb;29(1):75-9, 2008.

Gacia M, Safranow K, Gabryelewicz T, Styczyńska M, Pepłońska B, Dziedziejko V, Jakubowska K, Chlubek D, Zekanowski C, Barcikowska M. Two polymorphisms of presenilin-2 gene (PSEN2) 5′ regulatory region are not associated with Alzheimer’s disease (AD) in the Polish population.J Neural Transm.;115(1):85-90, 2008.

Mossakowska M, Barcikowska M, Broczek K, Grodzicki T, Klich-Raczka A, Kupisz-Urbanska M, Podsiadly-Moczydlowska T, Sikora E, Szybinska A, Wieczorowska-Tobis K, Zyczkowska J, Kuznicki J. Polish Centenarians Programme. Multidisciplinary studies of successful ageing: aims, methods, and preliminary results.Exp Gerontol. 2008 Mar;43(3):238-44. 6.

Lanni C, Racchi M, Mazzini G, Ranzenigo A, Polotti R, Sinforiani E, Olivari L, Barcikowska M, Styczynska M, Kuznicki J, Szybinska A, Govoni S, Memo M, Uberti D. Conformationally altered p53: a novel Alzheimer’s disease marker?Mol Psychiatry. Jun;13(6):641-7.2008.

Styczyńska M, Strosznajder JB, Religa D , Chodakowska-Żebrowska M, Pfeffer A, Gabryelewicz T, Czapski GA, Kobryś M, Karciauskas G, Barcikowska M. Association between genetic and environmental factors and the risk of Alzheimer’s disease. Folia Neuropathol; 46 (4): 165-17,2008

Klimkowicz-Mrowiec A, Marona M, Wołkow P, Maruszak A, Styczynska M, Barcikowska M, Zekanowski C, Szczudlik A, Slowik A.Interleukin-1 Gene -511 CT Polymorphism and the Risk of Alzheimer’s Disease in a Polish Population.Dement Geriatr Cogn Disord. Nov 20;28(5):461-464,2009.

Maruszak A, Safranow K, Gustaw K, Kijanowska-Haładyna B, Jakubowska K, Olszewska M, Styczyńska M, Berdyński M, Tysarowski A, Chlubek D, Siedlecki J, Barcikowska M, Zekanowski C.PIN1 gene variants in Alzheimer’s disease.BMC Med Genet. Nov 12;10:115, 2009

Golanska E, Hulas-Bigoszewska K, Sieruta M, Zawlik I, Witusik M, Gresner SM, Sobow T, Styczynska M, Peplonska B, Barcikowska M, Liberski PP, Corder EH.Earlier onset of Alzheimer’s disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.J Alzheimers Dis. Jun;17(2):359-68,2009.

Maruszak A, Canter JA, Styczyńska M, Zekanowski C, Barcikowska M. Mitochondrial haplogroup H and Alzheimer’s disease–is there a connection? Neurobiol Aging. Nov;30(11):1749-55, 2009.

Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK.GRN 3’UTR+78 C>T is not associated with risk for Parkinson’s disease. Eur J Neurol. Aug;16(8):909-11, 2009.

Vilarino-Güell C, Ross OA, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Lee MC, Hentati F, Uitti RJ, Wszolek ZK, Farrer MJ, Wu RM., An independent replication of PARK16 in Asian samples. Neurology. Dec 14;75(24):2248-9, 2010.

Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlström H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, Schofield PR., Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol. Nov;68(5):639-49 2010.

Vilarino-Güell C, Wider C, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA., Association of pyridoxal kinase and Parkinson disease. Ann Neurol. Mar;67(3):409-11,2010.

Uberti D, Cenini G, Bonini SA, Barcikowska M, Styczynska M, Szybinska A, Memo M. Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener Dis.;7(1-3):143-7, 2010.

Gaweda-Walerych K, Safranow K, Maruszak A, Bialecka M, Klodowska-Duda G, Czyzewski K, Slawek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Kurzawski M, Szczudlik A, Canter JA, Barcikowska M, Zekanowski C. Mitochondrial transcription factor A variants and the risk of Parkinson disease . Neurosci Lett. 2010 Jan 18;469(1):24-9. 2010.

Soto-Ortolaza AI, Behrouz B, Wider C, Vilarino-Güell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Calbindin-1 association and Parkinson’s disease. Eur J Neurol. Feb;17(2):208-11,2010

Gabryelewicz T, Masellis M, Berdynski M, Bilbao JM, Rogaeva E, St, George-Hyslop P, Barczak A, Czyzewski K, Barcikowska M, Wszolek Z, Black SE, Zekanowski C. Intra-Familial Clinical Heterogeneity due to FTLD-U with TDP-43, Proteinopathy Caused by a Novel Deletion in Progranulin Gene (PGRN).JAlzheimers Dis., Dec ;22(4):1123-33, 2010.

Gabryelewicz T, Berdynski M, Barczak A, Czyzewski K, Barcikowska M, Zekanowski C. Neuropsychiatric and Neuropsychological Features of frontotemporal dementia caused by novel deletion in progranulin gene (PGRN). Alzheimer’s & Dementia. Vol 6, Supl.1: 38-39, 2010

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K,JonesN, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C,Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; Alzheimer’s Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, DeStefano Barcikowska M,AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O’Donovan M, Amouyel P, Williams ., Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2APare associated with Alzheimer’s disease J.Nat Genet. May;43(5):429-35,2011.

Emilia J. Sitek, Anna Barczak, Ewa Narożańska1, Małgorzata Chodakowska-Żebrowska, Barbara Jasińska-Myga, Bogna Brockhuis, Mariusz Berdyński, Dariusz Wieczorek, Cezary Żekanowski, Seweryna Konieczna, Maria Barcikowska, Zbigniew K. Wszołek, Jarosław Sławek , The role of neuropsychological assessment in the detection of early symptoms in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP7) Acta Neuropsychologica vol. 9, no. 2, 209-226, 2011

Walecki J, Barcikowska M, Cwikła JB, Gabryelewicz T. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).Med Sci Monit. Dec 1;17(12):MT105-111,2011.

Maruszak A, Safranow K, Branicki W, Gawęda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C.The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer’s disease risk. J Alzheimers DisJan 1;27(1):197-210, 2011.

Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Passmore P, Morgan K; for the Alzheimer’s Research UK (ARUK) consortium, Younkin SG.Replication of EPHA1 and CD33 associations with late-onset Alzheimer’s disease: a multi-centre case-control study. Mol Neurodegener. ul 28;6(1):54, 2011

Klimkowicz-Mrowiec A, Marona M, Wolkow P, Witkowski A, Maruszak A, Styczynska M, Barcikowska M, Szczudlik A, Slowik A.Paraoxonase gene polymorphism and the risk for Alzheimer’s disease in the polish population.Dement Geriatr Cogn Disord.;31(6):417-23, 2011.

Dachsel JC, Wider C, Vilarino-Güell C, Aasly JO, Rajput A, Rajput AH, Lynch T, Craig D, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Heckman MG, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.Death-associated protein kinase 1 variation and Parkinson’s disease. Eur J NeurolAug;18(8):1090-3, . 2011.

Puschmann A, Verbeeck C, Heckman MG, Soto-Ortolaza AI, Lynch T, Jasinska-Myga B, Opala G, Krygowska-Wajs A, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA.Human leukocyte antigen variation and Parkinson’s disease. Parkinsonism Relat Disord. Jun;17(5):376-8, 2011.

Maruszak A, Pepłońska B, Safranow K, Chodakowska-Żebrowska M, Barcikowska M, Zekanowski C.TOMM40 rs10524523 polymorphism’s role in late-onset Alzheimer’s disease and in longevity. J Alzheimers Dis.;28(2):309-22. doi: 10.3233/JAD-2011-110743, 2012.

Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS,Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener. Apr 11;7:13. doi: 10.1186/1750-1326-7-13,2012.

Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G,Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, Opala G, Drozdzik M, Nishioka K, Farrer MJ, Ross OA, Wszolek ZK, Barcikowska M, Zekanowski C. PARK2 variability in Polish Parkinson’s disease patients–interaction with mitochondrial haplogroups.Parkinsonism Relat Disord. Jun;18(5):520-4,2012.

Gaj P, Paziewska A, Bik W, Dąbrowska M, Baranowska-Bik A, Styczynska M, Chodakowska-Żebrowska M, Pfeffer-Baczuk A, Barcikowska M, Baranowska B, Ostrowski J.Identification of a late onset Alzheimer’s disease candidate risk variant at 9q21.33 in Polish patients.J Alzheimers Dis.;32(1):157-68, 2012.

Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, Govoni S, Buoso E, Racchi M, Barcikowska M, Styczynska M, Szybinska A, Butterfield DA, Memo M, Uberti D.Conformational altered p53 as an early marker of oxidative stress in Alzheimer’s disease.PLoS One.;7(1):e29789. doi: 10.1371/journal.pone.0029789. , 2012

Soto-Ortolaza AI, Heckman MG, Labbé C, Serie DJ, Puschmann A, Rayaprolu S, Strongosky A, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Lynch T, Uitti RJ, Wszolek ZK, Ross OA.GWAS risk factors in Parkinson’s disease: LRRK2 coding variation and genetic interaction with PARK16.Am J Neurodegener Dis. Nov 29;2(4):287-99. eCollection ,2013.

Iyer A, Lapointe NE, Zielke K, Berdynski M, Guzman E, Barczak A, Chodakowska-Żebrowska M, Barcikowska M, Feinstein S, Zekanowski C.A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.PLoS One. 2013 Sep 27;8(9):e76409. doi: 10.1371/journal.pone.0076409. eCollection 2013.

Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Younkin SG, Petersen RC, Ertekin-Taner N, Uitti RJ, Meschia JF, Boylan KB, Boeve BF, Graff-Radford NR, Wszolek ZK, Dickson DW, Rademakers R, Ross OA.TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease.Mol Neurodegener. Jun 21;8:19. doi: 10.1186/1750-1326-8-19, 2013.

Mroczko B, Groblewska M, Barcikowska M. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.J Alzheimers Dis;37(2):273-83. doi: 10.3233/JAD-130647. Review,. 2013.

Lincoln S, Allen M, Cox CL, Walker LP, Malphrus K, Qiu Y, Nguyen T, Rowley C,Kouri N, Crook J, Pankratz VS, Younkin S, Younkin L, Carrasquillo M, Zou F, Abdul-Hay SO, Springer W, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Lewis JM, Dickson D, Graff-Radford NR, Petersen RC, Eckman E, Younkin SG, Ertekin-Taner N.LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer’s disease (LOAD).PLoS One. 2013 Jun 4;8(6):e64164. doi: 10.1371/journal.pone.0064164. 2013.

Sitek EJ, Narożańska E, Pepłońska B, Filipek S, Barczak A, Styczyńska M, Mlynarczyk K, Brockhuis B, Portelius E, Religa D, Barcikowska M, Sławek J, Żekanowski C.A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.PLoS One. 2013 Apr 12;8(4):e61074. doi:10.1371/journal.pone.0061074. Print 2013.

Peplonska B, Safranow K, Gaweda-Walerych K, Maruszak A, Czyzewski K, Rudzinska M, Barcikowska M, Zekanowski C.TOMM40 and APOE common genetic variants are not Parkinson’s disease risk factors.Neurobiol Aging. 2013 Aug;34(8):2078.e1-2. doi: 10.1016/j.neurobiolaging.2013.02.018. Epub 2013 Mar 21.

Golanska E, Sieruta M, Corder E, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, Klich I, Mossakowska M, Szybinska A, Barcikowska M, Liberski PP.The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians. Prion. 2013 May-Jun;7(3):244-7. doi: 10.4161/pri.23903. Epub 2013 Feb 13

Golanska E, Sieruta M, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, Klich I, Mossakowska M, Szybinska A, Barcikowska M, Liberski PP.APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians.Exp Gerontol. Apr;48(4):391-4. 2013 doi: 10.1016/j.exger.2013.01.013. Epub 2013 Feb 4.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilarino-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T,Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155. Erratum in: J Med Genet. Mar;50(3):202, 2013.

Sitek EJ, Narozanska E, Barczak A, Jasinska-Myga B, Harciarek M, Chodakowska-Zebrowska M, Kubiak M, Wieczorek D, Konieczna S, Rademakers R, Baker M, Berdynski M, Brockhuis B, Barcikowska M, Zekanowski C, Heilman KM, Wszolek ZK, Slawek J.Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?Neurocase.;20(1):69-86. doi: 10.1080/13554794.2012.732087. Epub 2012 , 2014

Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbé C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA..Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson’s disease.Neurobiol Aging. Aug;35(8):1958.e1-2. doi: 2014

Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB, Aasly JO, Barcikowska M, Siuda J, Wszolek ZK, Ross OA, Carrasquillo M, Dickson DW, Graff-Radford N, Petersen RC, Ertekin-Taner N, Morgan K, Bu G, Younkin SG.ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease.Mol Neurodegener. Mar 10;9:11. doi: 10.1186/1750-1326-9-11, 2014.

Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbé C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA. Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson’s disease.Neurobiol Aging. 2014 Aug;35(8):1958.e1-2. doi: 10.1016/j.neurobiolaging.2014.03.004. Epub 2014 Mar 5.

Baranowska-Bik A, Bik W, Styczynska M, Chodakowska-Zebrowska M, Barcikowska M, Wolinska-Witort E, Kalisz M, Martynska L, Baranowska B.Plasma leptin levels and free leptin index in women with Alzheimer’s disease.Neuropeptides. 2015 Aug;52:73-8. doi: 10.1016/j.npep.2015.05.006. Epub 2015 Jun 3.

Labbé C, Ogaki K, Lorenzo-Betancor O, Carrasquillo MM, Heckman MG, McCarthy A, Soto-Ortolaza AI, Walton RL, Lynch T, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Dickson DW, Uitti RJ, Wszolek ZK, Ross OA. Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus.PLoS One. 2015 Jun 19;10(6):e0128586. doi: 10.1371/journal.pone.0128586. eCollection 2015.

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Narożańska E, Konkel A, Dąbrowska M, Barcikowska M, Sławek J. Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.Neurol Neurochir Pol. 2015;49(4):217-22. doi: 10.1016/j.pjnns.2015.05.004. Epub 2015 Jun 6.

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Barcikowska M, Sławek J.Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer’s disease and mild cognitive impairment? Neurol Neurochir Pol. 2015;49(4):239-44. doi: 10.1016/j.pjnns.2015.06.001. Epub 2015 Jun 17.

Warchol-Celinska E, Styczynska M, Prejbisz A, Przybylowska K, Chodakowska-Zebrowska M, Kurjata P, Piotrowski W, Polakowska M, Kabat M, Zdrojewski T, Drygas W, Januszewicz A, Barcikowska M.Hypertension in patients with Alzheimer’s disease–prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland.J Am Soc Hypertens. 2015 Sep;9(9):711-24. doi: 10.1016/j.jash.2015.07.002. Epub 2015 Jul 9.

Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza AI, Labbe C, Walton RL, Strongosky AJ, van Gerpen JA, Uitti RJ, McLean PJ, Springer W, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, McCarthy A, Lynch T, Puschmann A, Rektorova I, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Ferman TJ, Boeve BF, Petersen RC, Parisi JE, Graff-Radford NR, Dickson DW, Wszolek ZK, Ross OA. DNAJC13 p.Asn855Ser mutation screening in Parkinson’s disease and pathologically confirmed Lewy body disease patients.Eur J Neurol. 2015 Sep;22(9):1323-5. doi: 10.1111/ene.12770.

Labbé C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorová I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.Neurology. 2015 Nov 10;85(19):1680-6. doi: 10.1212/WNL.0000000000001946. Epub 2015 Sep 2. Erratum in: Neurology. 2015 Nov 10;85(19):1728.

Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbé C, Lorenzo-Betancor O, Moussaud-Lamodière EL, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Puschmann A, Nishioka K, Funayama M, Hattori N, Parisi JE, Petersen RC, Graff-Radford NR, Boeve BF, Springer W, Wszolek ZK, Dickson DW, Ross OA. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. Neurology. 2015 Dec 8;85(23):2016-25. doi: 10.1212/WNL.0000000000002170. Epub 2015 Nov 11.

Nesteruk M, Nesteruk T, Styczyńska M, Barczak A, Mandecka M, Walecki J, Barcikowska-Kotowicz M. Predicting the conversion of mild cognitive impairment to Alzheimer’s disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging. Neurol Neurochir Pol. 2015;49(6):349-53. doi: 10.1016/j.pjnns.2015.09.003. Epub 2015 Sep 15.

Nesteruk T, Nesteruk M, Styczyńska M, Barcikowska-Kotowicz M, Walecki J.Radiological Evaluation of Strategic Structures in Patients with Mild Cognitive Impairment and Early Alzheimer’s Disease.Pol J Radiol. 2016 Jun 19;81:288-94. doi: 10.12659/PJR.896412. eCollection 2016.

Mandecka M, Budziszewska M, Barczak A, Pepłońska B, Chodakowska-Żebrowska M, Filipek-Gliszczyńska A, Nesteruk M, Styczyńska M, Barcikowska M, Gabryelewicz T.Association between Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease.J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction. PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.

Nesteruk M, Nesteruk T, Styczyńska M, Mandecka M, Barczak A, Barcikowska M. Combined use of biochemical and volumetric biomarkers to assess the risk of conversion of mild cognitive impairment to Alzheimer’s disease. Folia Neuropathol. 2016;54(4):369-374. doi: 10.5114/fn.2016.64815.